Established since 1963, with an annual sales turnover of 500 million US dollars, Boryung Pharmaceutical is a fully integrated pharmaceutical company located in Seoul with over 1300 employees. The headquarter is located in Seoul, and there are two manufacturing sites in Ansan and Yesan.

We are one of Korea’s foremost oncology injections manufacturers and are very keen on exploring opportunities with global companies.
Boryung pharmaceutical could become the #1 oncology company through the robust quality of all of our oncology injections for many years. 
Kanarb is the #1 ranked Original ARB product which is proven to have superior Blood Pressure Lowering Effect compared to Losartan and Valsartan.
[Portfolio of Kanarb family]
 Kanarb: Fimasartan
 Kanarb Plus: Fimasartan +HCTZ
 Dukarb: Fimasartan + Almodipine
 Tuvero: Fimasartan + Rosuvastatin
 Dukaro: Fimasartan + Almodipine + Rosuvastatain
 Akarb: Fimasratn + Atorvastatin